Patrick J. Wethington

Endocardial Solutions, Inc. designs, develops and manufactures a minimally invasive diagnostic system that diagnoses within the span of a few heartbeats, arrhythmia, a potentially fatal abnormal heart rhythm. The company's EnSite catheters and clinical workstations produce a high-resolution, real-time, three-dimensional color display of electrical activity in the heart chamber, thus allowing electrophysiologists to locate and diagnose tachycardia in real-time and to determine the course of treatment. It was founded in 1992. The company is located in St. Paul, MN.

CHF Solutions, Inc. is a privately held manufacturer of innovative medical devices for cardiac care and the developer of the aquapheresis therapy and the Aquadex FlexFlow Fluid Removal system. Fluid overload is failure to eliminate excess fluid, primarily salt and water, from the body. While many conditions such as renal failure, metabolic disease and post surgical conditions may result in fluid overload, congestive heart failure is a leading cause. Aquapheresis therapy and the Aquadex FlexFlow Fluid Removal system are designed specifically for use by physicians to safely, effectively, and conveniently treat fluid overloaded patients by removing excess salt and water. With aquaphereis, the physician specifies the amount of fluid to be removed from a patient's blood at a controlled rate and the system does so in a highly controlled and effective way.

St. Jude Medical LLC develops, manufactures and distributes cardiovascular medical devices for the global cardiac rhythm management, cardiovascular and atrial fibrillation therapy areas and neurostimulation medical devices for the management of chronic pain. The company was founded by Manuel A. Villafana in 1976 and is headquartered in St. Paul, MN.

Hemosphere, Inc. operates as a medical device company. It engages in the development and commercialization of a vascular access device for treating hemodialysis patients with compromised vasculature. The company was founded in 1998 and is headquartered in Eden Prairie, MN.

CardioInsight Technologies, Inc. manufactures and develops electrocardiographic mapping technology. It has developed a novel three dimensional (3D) non-invasive Electrocardiographic Mapping technology platform combining body surface electrical data with heart-torso anatomy to provide single beat epicardial 3D electroanatomic maps of the whole heart. Its ECVUE™ system non-invasively generates real-time, whole heart images of the electrical activity on the surface of the heart by combining body surface electrical data with 3D anatomical data. It then reconstructs and displays 3D maps and other useful measures of cardiac electrical activity as if the measurements were taken directly from the surface of the heart. The company was founded by Charu Ramanathan in 2006 and is headquartered in Cleveland, OH.

Guidant Corp. manufactures cardiovascular therapeutic devices. The company also provides cardiac and peripheral vascular repair surgical systems. It operates in Europe and Japan. Guidant was founded in 1994 and is headquartered in St. Paul, MN.

Bardy Diagnostics, Inc. manufactures medical devices. It offers medical device technology, cardiology, and electrophysiology. The company was founded by Gust H. Bardy in 2013 and is headquartered in Seattle, WA.

CardioFocus, Inc. engages in the development and market of catheter-based approach to treating atrial fibrillation. The company was founded by Edward Sinofsky in 1990 and is headquartered in Marlborough, MA.